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Purpose: To determine whether eye drop instillation of the disaccharide trehalose (TT) alleviates ocular surface damage
in a dry eye murine model.
Methods: Dry eye was induced in mice using an intelligently controlled environmental system (ICES). After 21 days
housed in the ICES without topical treatment, the mice were randomly divided into three groups: no eye drops (ICES) for
three weeks, four times a day with PBS 0.01 M 10 µl/eye bilaterally (ICES+PBS), or with TT 87.6 mM 10 µl/eye bilaterally
(ICES+TT). Another mice group that was not exposed to the ICES and received no treatment served as a control group
(UT). The ocular surface integrity, in each group, was evaluated using Oregon Green dextran (OGD) and fluorescein
staining. The expression and distribution of occludin, involucrin, and small proline-rich protein 2 were determined with
immunohistology analysis on whole mounted corneas. Heat shock protein 70 (HSP70) and matrix metalloproteinase 9
(MMP-9) expression was estimated with immunohistology. Ocular surface inflammation associated with each treatment
was estimated with real time-PCR of interleukin-1β (IL-1β), IL-2, IL-6, IL-17, and tumor necrosis factor-alpha in the
conjunctiva.
Results: OGD staining in the cornea epithelium was lower in the ICES+TT group than in the ICES and ICES+PBS groups.
Corneal epithelial occludin staining was markedly more homogenous in the ICES+TT group than in ICES and ICES+PBS
groups, and there were no desquamating apical epithelial cells. Involucrin and small proline-rich protein 2 labeling of
whole mounted corneas revealed upregulation of their expression in the groups, which received no treatment or PBS
instillation compared to the ICES+TT group. HSP70 and MMP-9 immunolabeling revealed a marked increase in corneal
epithelial expression in response to the ICES. The group treated with trehalose showed a similar profile expression of
HSP70 and MMP-9 as the control group (UT). Conjunctival IL-1β, IL-2, IL-6, IL-17, tumor necrosis factor-alpha (TNF-
α), and MMP-9 mRNA expression was lower in the ICES+TT group than in the ICES or ICES+PBS group.
Conclusions: Trehalose application restored ocular surface integrity, suppressed inflammatory and proteolytic MMP-9
and HSP70 expression, and keratinization in mice with dry eye damaged by a desiccative model.
Over the past 10 years, substantial progress has been
made in identifying dry eye disease (DED) pathophysiology.
DED is now recognized as a multifactorial disease resulting
in inadequate hydration of the ocular surface leading to tear
film hyperosmolarity and eventually to clinical symptoms of
discomfort, declines in ocular surface epithelial renewal, and
visual disturbance [1]. Hyperosmolarity is known to induce
ocular surface inflammatory responses [2], mainly through the
activation  of  receptors  that  also  induce  pain.  One  is  the
transient receptor potential vanilloid type 1 (TRPV1) whose
activation  by  hypertonicity  in  cell  culture  induces
Correspondence to: Wei Chen, 270 XueYuan West Road, Wenzhou
Zhejiang Province, 325027, People’s Republic of China; Phone:
86-577-88068878;  FAX:  86-577-88832083;  email:
chenweimd@hotmail.com
inflammatory  responses  [3].  These  biologic  consequences
account for the ocular surface injury reported in more than
80% of patients with DED altering their quality of life [1].
Whatever  the  level  of  dry  eye  severity,  frequent
applications  of  artificial  tears  remain  a  widely  accepted
therapy for DED. Used over the past 30 years, this treatment
has proved that it is able to provide noteworthy symptomatic
relief [4]. Nevertheless, the remaining challenge is to improve
tear film supplementation efficacy by including more efficient
active  ingredients  or  excipients  to  optimize  ocular
moisturizing and prevent epithelium injury.
Trehalose (TT) is a non-reducing disaccharide of glucose
naturally  widespread  in  many  living  organisms,  including
plants,  insects,  fungi,  and  bacteria.  Trehalose  has  been
identified  as  a  key  response  element  needed  for  survival
during  exposure  to  stress-induced  desiccation.  Trehalose
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317decreases damage to cells caused by desiccation by serving as
a “water replacement” or rearranging the intracellular water
structure [5]. Matsuo et al. [6] first explored the potential
beneficial effect of trehalose on human cells in DED stressed
by  desiccation.  Furthermore,  Cejková  et  al.  described  a
protective effect of trehalose on ultraviolet B–induced corneal
damage  in  terms  of  oxidative  stress,  apoptosis  [7],  and
inflammation [8]. We recently showed in a murine dry eye
model designated as an ICES that trehalose improves ocular
surface  epithelial  health  in  vivo  during  exposure  to
desiccation through declines in apoptosis [9]. However, a
more extensive characterization of the effects of exposure to
ICES desiccation on ocular surface epithelial disorders has not
yet been well investigated.
We  describe  here  in  mice  exposed  to  the  ICES  that
application of trehalose containing eyedrops alleviates DED
corneal  damage  to  tight  junction  proteins  and  decreases
epithelial cornification as well as conjunctival inflammation.
Taken  together,  our  findings  strengthen  the  notion  that
trehalose application may provide an improved therapeutic
strategy for DED.
METHODS
Animals: All procedures were approved by the Animal Care
and  Ethics  Committee  of  Wenzhou  Medical  College,
Zhejiang, China, and adhered to the Association for Research
in  Vision  and  Ophthalmology  Statement  for  the  Use  of
Animals in Ophthalmic and Vision Research. A total of 120
female C57BL/6 mice (age range, 4–6 weeks) were supplied
by the Animal Breeding Unit of Wenzhou Medical College.
Murine dry eye model: This study used a novel murine model
of  dry  eye  induced  by  an  intelligently  controlled
environmental system (ICES) [9]. Mice in a control group
were maintained in relative humidity, 60%–80%, no airflow,
and at 21–23 °C. Dry eye desiccation was created through
exposure to relative humidity of 13.1±3.5%, an airflow of
2.2±0.2 m/s, and 22±2 °C.
Therapeutic regimen: C57BL/6 mice were used in this study.
After 21 days housed in the ICES without topical treatment,
mice were randomized into three groups: a) a group that did
not receive any topical treatment (ICES); b) a group that
received 10 µl/eye 0.01 M PBS (0.01 M, pH 7.4; Maixin
Technology, Fujian, China) bilaterally four times a day (ICES
+PBS);  and  c)  a  group  that  received  10  µl/eye  trehalose
(30 mg/ml, 87.6 mM; Théa laboratories, Clermont Ferrand,
France) bilaterally four times a day (ICES+TT). Both treated
groups received topical eye drops on the same daily regimen
for 3 weeks. Normal C57BL/6 mice not housed in the ICES
that did not receive any topical treatment (UT) were used as
controls.
Corneal  fluorescein  and  Oregon  Green  dextran  staining:
Corneal epithelial staining with Oregon Green dextran (OGD;
70,000 MW; Invitrogen Inc., Grand Island, NY) was assessed
in the three different groups. Briefly, 0.5 μl of 50 μg/ml OGD
was instilled in the ocular surface 1 min before euthanasia.
Corneas were rinsed with 2 ml PBS and photographed with a
stereoscopic  zoom  microscope  (V20;  Zeiss  with  krypton-
argon and He-Ne laser; Carl Zeiss Meditec, Ltd., Thornwood,
NY) under ﬂuorescence excitation at 470 nm. Images were
obtained 2 h after instillation of the last treatment drop and
were  processed.  The  fluorescein  solution  contained  1  mg
fluorescein sodium in 0.5 ml PBS. The severity of corneal
OGD staining shown in digital images was graded by two
masked  observers,  using  the  Baylor  grading  scheme  for
corneal  ﬂuorescent  staining.  The  number  of  fluorescein
staining dots were graded in the 1-mm central cornea zone of
each eye, on a standardized five-point scale (0 dot, grade 0;
1–5 dots, grade 1; 6–15 dots, grade 2; 16–30 dots, grade 3; 30
dots, grade 4). One point was added to the score if there was
one area of confluent staining, and two points were added for
two or more areas of confluence.
Immunofluorescent staining: Occludin, involucrin, and small
proline-rich protein 2 (SPRR-2) were evaluated with laser
scanning confocal microscopy in whole mounted corneas, and
heat shock protein 70 (HSP70) and matrix metalloproteinase
9 (MMP-9) were evaluated in tissue sections.
The  eyes  of  mice  from  each  group  were  excised,
embedded in optimal cutting temperature compound (OCT
compound; VWR, Suwanee, GA), and flash frozen in liquid
nitrogen. Sagittal 8-µm sections were cut with a cryostat (HM
550; Microm, Waldorf, Germany) and placed on glass slides
that were stored at –80 °C. The whole corneas from each group
(three corneas/group per experiment, in three different sets of
experiments) were freshly harvested. Tissues were fixed with
either methanol at 4 °C for 10 min (occludin, HSP70, and
MMP-9)  or  acetone  at  –20  °C  for  5  min  (involucrin  and
SPRR-2). After fixation, they were permeabilized with PBS
containing 0.1% Triton-X for 10 min. Then they were blocked
with 20% normal goat serum in PBS for 45–60 min (HSP70,
MMP-9, occludin, and SPRR-2) or 20% normal horse serum
(involucrin).  Primary  polyclonal  rabbit  antibody  against
HSP70  (1:100  dilution;  Boster  Bio-engineering  Limited
Company, Wuhan, China), polyclonal rabbit antibody against
MMP-9  (1:100  dilution;  Abcam,  Cambridge,  MA),
polyclonal rabbit antibody against occludin (1:50 dilution,
5 μg/ml; Zymed, San Francisco, CA), polyclonal rabbit serum
against  SPRR-2  (1:100  dilution  of  neat  serum;  Alexis
Biochemicals,  San  Diego,  CA),  or  polyclonal  goat  anti-
involucrin (1:20 dilution, 2 μg/ml; Santa Cruz Biotechnology,
Santa Cruz, CA) were applied and incubated for 12 h at 4 °C.
Secondary  antibodies,  Alexa-Fluor  488-conjugated  goat
antirabbit immunoglobulin G (1:300; Invitrogen, Molecular
Probes, Eugene, OR) or Alexa-Fluor 488-conjugated donkey
antigoat  immunoglobulin  G  (1:300;  Invitrogen  Molecular
Probes), were then applied and incubated in a dark chamber
for 1 h, followed by counter-staining with propidium iodide
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318(1:200  dilution)  or  4',6-diamidino-2-phenylindole  (1:1,000
dilution) for 30 min.
Whole corneas were flattened on microscope slides and
covered with antifade mounting medium (Beyotime Institute
of Biotechnology, Shanghai, China), and then coverslips were
applied.  Cryosections  and  whole  mounted  digital  images
(512×512  pixels)  were  captured  with  a  laser-scanning
confocal microscope (LSM 710; Zeiss with krypton-argon
and He-Ne laser; Carl Zeiss Meditec, Sartrouville, France)
with 488-excitation and 543-nm emission filters (LP505 and
LP560, respectively). They were acquired with a 40/0.75×
objective. Images from treatment and control corneas were
captured with identical photomultiplier tube gain settings and
processed using the microscope software (ZEN 2008; Carl
Zeiss Meditec) and image-analysis software (Photoshop CS5;
Adobe Inc., San Jose, CA).
RNA isolation and quantitative real-time polymerase chain
reaction:  Total  RNA  from  conjunctivas  (two  eyes/group/
experiment) were extracted and pooled from each of the four
experimental groups, using the RNA isolation kit according
to the manufacturer’s instructions (PicoPure RNA isolation
kit, 40 isolations; Arcturus; Applied biosystems, Foster City,
CA).  The  RNA  concentration  was  measured  based  on  its
optical density at 260 nm and stored at −80 °C before use.
cDNA was synthesized from 1 μg of total RNA using random
primer  and  Moloney  Murine  Leukemia  Virus  reverse
transcriptase.  Quantitative  real-time  polymerase  chain
reaction (qRT–PCR) analysis was employed using the SYBR
Green  PCR  Core  Reagents  System  (Applied  Biosystems,
Paisley, UK) and Applied Biosystems 7500 Real-Time PCR
System (Applied Biosystems). The primers are provided in
Table 1. Assays were performed in duplicate and repeated
three  times  using  different  samples  from  different
experiments. The qRT–PCR results were analyzed using the
comparative  threshold  cycle  method  and  normalized  with
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as an
endogenous reference.
Data analysis: The 2-Ct method [10] was used to analyze the
relative changes in gene expression from real-time RT–PCR
experiments. Statistical comparisons of four groups for real-
time PCR were performed with ANOVA (SPSS 13.0, IBM
Corporation,  NY),  with  p<0.05  considered  statistically
TABLE 1. PRIMER SEQUENCES USED FOR QRT–PCR.








Figure 1. Corneal staining with OGD and fluorescein sodium.
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319significant. The Mann–Whitney test was used to compare the
controls (UT versus ICES) and the treatment groups (ICES
+PBS versus ICES+TT). p<0.05 was considered statistically
significant.  Analyses  were  performed  using  SPSS  13.0
software.
RESULTS
Effects of intelligently controlled environmental system on
corneal dye staining: To assess changes in corneal epithelial
integrity, fluorescein and OGD dye staining were evaluated.
Compared  with  the  UT  group,  corneal  uptake  of  OGD
increased in the ICES group. There were more alterations in
the cell–cell contacts at the tight junctions and more extensive
epithelial desquamation based on more widespread punctuate
and confluent staining. On the other hand, the TT group had
less corneal staining than either the ICES or the ICES+PBS
group. The Baylor grading scheme used to score the staining
areas confirmed the protective effect of trehalose (Figure 1,
Figure 2, and Table 2). The grading showed the average OGD
staining score in eyes treated with trehalose was significantly
less than PBS (1.2±0.45 versus 3.6±0.55, p<0.01).
Superficial  corneal  epithelial  layer  cornification  and
desquamation:  Occludin  expression  indicates  corneal
epithelial  barrier  function  and  tight  junctional  integrity.
Occludin  distribution  of  whole  mounted  corneas  was
Figure 2. Corneal Oregon Green Dextran staining scores.
presumed to be normal in the UT corneas based on limited
fluorescein staining and epithelial cell membrane continuity.
Nevertheless, in some peripheral areas, cells were detached
from the apical corneal epithelium, but this was rarely seen in
the central regions. However, in the ICES group, there was a
markedly  increased  number  of  desquamating  cell  areas
whereas in the ICES+TT group the corneal epithelium was
more homogenous and continuous than in the mice treated
instead with PBS (Figure 3).
In whole mount corneas of the UT group, the cytoplasmic
confocal images showed that the cornified envelope proteins,
involucrin and SPRR-2, were weakly stained. Their labeling
in the ICES and ICES+PBS groups was less homogenous with
mixed areas of intense and low fluorescence intensity. In
contrast, in the ICES+TT and UT groups, both proteins had
similar expression profiles (Figure 4 and Figure 5).
Effects of intelligently controlled environmental system on
heat shock protein 70 expression profiles: In the UT group,
there was low-intensity HSP70 immunostaining in the apical
epithelium. However, in the ICES group HSP70 staining was
markedly increased in the apical and basal corneal epithelium.
Some of this more intense staining was reduced in the ICES
+PBS group. In the ICES+TT group, HSP70 apical epithelium
immunostaining was greater than that in the UT group, but
lower than in the ICES and ICES+PBS groups. Furthermore,
the ICES+TT group had no HSP70 labeling in the basal area
of the corneal epithelium (Figure 6).
Effects of intelligently controlled environmental system on
matrix  metalloproteinase  9  expression  profiles:  MMP-9
immunolabeling in the control UT group was homogenously
low  in  all  layers  of  the  corneal  epithelium.  The  staining
distribution was the same in the four groups, but with diverse
intensities. In the ICES and ICES+PBS groups, staining was
consistently more intense than in the UT and ICES+TT groups
(Figure 7).
Effects of intelligently controlled environmental system on
inflammatory  cytokine  and  matrix  metalloproteinase  9
expression profiles: Real-time PCR evaluated interleukin-1β
(IL-1β), IL-2, IL-6, IL-17, tumor necrosis factor-alpha (TNF-
α),  and  MMP-9  mRNA  expression  levels,  which  were
normalized by the housekeeping gene GAPDH. This was done
by using pooled total RNA samples of conjunctiva from the
UT  and  the  three  different  ICES  groups.  The  mRNA
expression  levels  for  each  factor  were  higher  in  the
TABLE 2. OREGON GREEN DEXTRAN STAINING SCORES.
Group UT ICES ICES + PBS ICES + TT
OGD staining score (n=5) 0.4±0.55 5.0±0.71 3.6±0.55 1.2±0.45
    p<0.01   p<0.01
               Data are shown as mean±SD. Probabilities compare UT versus ICES and ICES + PBS versus ICES +TT.
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320Figure 3. Immunoﬂuorescent staining of whole-mounted corneas stained for occludin. Arrows: desquamating apical epithelial cells; asterisk:
holes resulting from the detached cells.
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321Figure 4. Immunoﬂuorescent staining of whole-mounted corneas stained for involucrin.
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322Figure 5. Immunoﬂuorescent staining of whole-mounted corneas stained for SPRR-2.
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323conjunctiva of the ICES group than those in the ICES+PBS
and the UT as well as the ICES+TT groups. IL-1β and IL-6
mRNA upregulation was particularly pronounced in the ICES
and  ICES+PBS  groups.  Trehalose  treatment  lowered
conjunctival  MMP-9  expression.  Furthermore,  the  mRNA
expression levels of each factor in the ICES+TT and UT
groups were not different from one another (Figure 8 and
Figure 9).
DISCUSSION
We showed in a novel murine dry eye model induced with an
ICES  that  eyedrop  supplementation  with  the  disaccharide
trehalose improves corneal surface hydration and protects
against losses in epithelial integrity more than a physiologic
solution.  Preservation  of  integrity  was  attributable  to
improved  organization  of  epithelial  cell  junctions,  lower
proinflammatory cytokine and MMP-9, and gene expression
Figure 6. Immunoﬂuorescent staining in tissue sections stained for HSP70.
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324upregulation, presumably due to less pathogenic infiltration,
less keratinization, and upregulation of stress markers.
The  ICES  dry  eye  model  is  more  representative  of
environmental challenges to maintaining epithelial integrity
since this model mimics the effects of a decrease in ambient
humidity that induces dry eye symptomology. Other studies
have indicated that the ICES model is relevant because losses
in tear film stability described in patients with DED exposed
to airflow [11], air pollutants, or dry air at high altitude [12],
dry climates mimic those induced in mice by ICES. Dursun
et al. [13] showed in a controlled environment chamber model
using mice that blockade with scopolamine in a desiccating
environment  potentiated  changes  in  tear  film  properties
exposed to a continuous airflow. In another study, DED was
induced  in  an  environment  chamber  by  controlling
temperature  and  airflow  at  low  humidity  without  any
Figure 7. Immunoﬂuorescent staining in tissue sections stained for MMP-9.
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325pharmacological agent injection and/or surgical intervention
[14]. The study demonstrated that tear film stability mainly
depends on temperature, airflow, and humidity. The ICES
model used in this study is an improvement on the controlled
environment chamber dry eye model. Our ICES maintains
constant  airflow,  temperature,  and  humidity  by  intrinsic
cycling, which does not modify the temperature and humidity
level. This more efficient desiccant system allowed increased
chamber size and animal population [9].
Fluorescein and OGD staining determined ocular surface
integrity.  The  results  showed  corneal  staining  was  more
extensive and pervasive in deeper layers in the ICES than in
the UT and ICES+TT groups. The PBS group presented an
intermediate score due to the moisturizing property of PBS,
which may itself be considered a tear substitute. Less staining
in the ICES+TT suggests that this disaccharide reduced losses
in epithelial integrity more than that seen in the other groups.
Occludin  is  a  major  tight  junction  protein  of  the  corneal
epithelium and contributes to support of its barrier function
[15,16]. Decreases in occludin staining in the ICES and ICES
+PBS groups were most likely responsible for the increase in
corneal staining in the ICES group. Depressed barrier function
was consistent with more desquamating apical epithelial cells
in the ICES and ICES+PBS groups compared to the UT and
ICES+TT groups.
Cornified  envelope  involucrin  and  SPRR-2  protein
expression  in  skin  forms  a  protective  cornified  envelope
structure at the terminal stage of keratocyte differentiation
[17]. In the ocular surface, these proteins are upregulated
when the epithelium is exposed to external injury resulting
from desiccative stress [18]. This corneal and conjunctival
epithelial keratinization response can severely impair visual
function [19]. Furthermore, these proteins can disrupt tear
film  stability  by  entrapping  soluble  mucins  produced  by
goblet cells [20]. We showed here that trehalose instillation
prevented involucrin and SPRR-2 upregulation, which could
account for increases in tear film stability.
Inflammation  is  a  hallmark  of  DED  since  there  are
improved  clinical  signs  in  patients  receiving  topical
corticosteroids [21] and cyclosporine A [22]. The increases in
the Th1 [23] and Th17 [24-26] pathways appear to play a
prominent  role  during  chronic  inflammation  and  tissue
destruction in DED. Even though trehalose treatment does not
change the balance between the T cell effectors and their
regulators (Treg cells), the ability of the latter to suppress T
cell activation seems to be affected in DED, especially for
Th17. Th17 cells produce IL-17, which induces resident cell
secretion of proinflammatory cytokines, such as IL-1, TNF-
α,  and  IL-6  [27],  and  metalloproteinases  such  as  MMP-9
[26] giving rise to corneal epithelial barrier disruption. These
events are simulated in our model as were those of others since
IL-1, TNF-α, and IL-6 were upregulated [28]. On the other
hand,  trehalose  reduced  proinflammatory  cytokine
upregulation compared to the PBS group. This decrease is
noteworthy since PBS by itself is commonly used as a tear
supplement in DED. This difference suggests that trehalose
could offer a protective effect against the initiation and/or
progression  of  inflammation  in  DED  in  addition  simply
Figure  8.  Real-time  PCR  analysis  of
IL-1β, IL-2, IL-6, and IL-17 mRNA in
mice conjunctiva.
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326providing lubrication and ocular surface hydration. Moreover,
in the artificial tears field, very few compounds have been
shown  to  present  biologic  anti-inflammatory  functions.
Except  trehalose  [8],  only  hyaluronan,  in  addition  to  his
primary moisturizing properties, have been reported in in vitro
studies or in clinical trials to present some anti-inflammatory
efficiency by reducing inflammatory cytokines such as IL-6
and Il-8 [29] or an inflammatory-related antigen such as major
histocompatibility complex class II human leukocyte antigen
DR [30]. To our knowledge, no study has compared the anti-
inflammatory biologic functions of these compounds.
Another indicator of DED is metalloproteinase gelatinase
MMP-9 tear upregulation in a murine DED model [31] and in
patients with DED [32]. Expression is low in healthy eyes
[32] and is related to DED since the loss [33] and inhibition
[34] of MMP-9 expression in DED models alleviate ocular
surface disruption. MMP-9 cleaves to the epithelial basement
membrane and tight junction proteins such as occludin [15],
which maintain epithelial barrier function [16]. Upregulation
of MMP-9 causes ocular surface epithelial cell detachment as
well as tight junction disruption. Such changes may lead to
increases in corneal barrier permeability. Trehalose treatment
in  the  current  study  lowered  corneal  epithelial  and
conjunctival MMP-9 gene expression more than that in mice
that received no treatment or PBS supplementation instead.
These  considerations  suggest  that  trehalose  may  lower
MMP-9 expression as a consequence of suppressing innate
immune responses associated with increases in IL-1, TNF-α
[35], and IL-17 [26] proinflammatory cytokine release, which
induce MMP-9 upregulation in DED.
Heat shock proteins such as HSP70 are upregulated by
elevated  temperature  [36],  hypoxia  [37],  oxidative  stress
[38] and desiccation [39]. HSP70 restores homeostasis by
decreasing protein turnover and preserving conformation and
function [40]. This adaptive response by HSP70 expression
levels makes it a useful biomarker for assessing cell damage.
We  found  that  HSP70  expression  in  mice  treated  with
trehalose was lower than that in the PBS and ICES groups,
further indicating that trehalose lessens declines in ocular
surface  integrity  resulting  from  exposure  to  the  stresses
imposed by the ICES.
In addition, it is widely accepted that trehalose can protect
cells against desiccation. Trehalose was reported to be more
efficient  for  treating  dry  eye  syndrome  than  commercial
eyedrops  containing  hyaluronan  or  hydroxyethylcellulose
[41]. This beneficial effect is also attributable to trehalose’s
ability  to  protect  cell  membranes  [42]  and  proteins  from
oxidative injury by acting as a free-radical scavenger [43].
Furthermore,  trehalose  suppresses  proinflammatory
phenotype activation in macrophages in experimental septic
shock [44] and in a model of peritoneal inflammation by
protecting against I-kappa B-alpha dephosphorylation [45].
Trehalose  supplementation  also  protects  against  apoptosis
[9].
Figure  9.  Real-time  PCR  analysis  of
TNF-α  and  MMP-9  mRNA  in  mice
conjunctiva.
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327Taken together, the findings of the present study confirm
that  trehalose  supplementation  may  provide  a  therapeutic
option for treating ocular surface diseases such as DED.
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